Pfizer Technical Analysis Summary
Date: November 20, 2026
Overview
Pfizer's stock has recently broken below the critical support level of $28.50, indicating a bearish trend. This level was significant as it represented both a support zone and a Fibonacci retracement level from previous price movements.
Key Technical Levels
- Current Price Action: Pfizer has breached the support zone at $28.50.
- Next Support Level: The stock is likely to decline towards the next support level at $27.00.
- Fibonacci Levels: The $28.50 level corresponds to the 38.2% Fibonacci retracement of the upward impulse that began in July.
- Previous Resistance: The $28.50 level had previously capped the price in April and turned into support after a breakout in October.
Market Sentiment
The overall sentiment in the large-cap pharmaceutical sector has been bearish, with a nearly 2% decline attributed to setbacks in Merck’s pipeline and ongoing scrutiny regarding US drug pricing. Despite Pfizer's recent $2.6 billion licensing deal for early-stage CAR-T programs, the stock has not seen a positive reaction.
Future Outlook
If the stock price holds at the $27.00 support level, it may signal the end of the current correction phase, allowing Pfizer to potentially resume its upward trend towards the $28.50 level. However, a daily close above $29.75 would negate the current bearish outlook.
Conclusion
In the near term, sellers are expected to maintain control as long as the price remains below $28.50. Investors should monitor the $27.00 support level closely for signs of a potential reversal or further decline.